Gena Wang

Stock Analyst at Barclays

(2.25)
# 2,661
Out of 4,893 analysts
203
Total ratings
40.3%
Success rate
-2.83%
Average return

Stocks Rated by Gena Wang

Ionis Pharmaceuticals
Jul 1, 2025
Upgrades: Overweight
Price Target: $51$57
Current: $42.83
Upside: +33.08%
Sarepta Therapeutics
Jun 17, 2025
Maintains: Overweight
Price Target: $89$29
Current: $19.37
Upside: +49.72%
Avidity Biosciences
Jun 10, 2025
Maintains: Overweight
Price Target: $57$59
Current: $31.27
Upside: +88.68%
Solid Biosciences
May 16, 2025
Maintains: Overweight
Price Target: $15$10
Current: $5.52
Upside: +81.16%
Sangamo Therapeutics
May 14, 2025
Maintains: Overweight
Price Target: $9$5
Current: $0.53
Upside: +850.39%
Cellectis
May 13, 2025
Maintains: Overweight
Price Target: $5$4
Current: $1.63
Upside: +146.15%
CRISPR Therapeutics AG
May 9, 2025
Maintains: Equal-Weight
Price Target: $56$42
Current: $60.08
Upside: -30.09%
4D Molecular Therapeutics
May 9, 2025
Maintains: Overweight
Price Target: $45$38
Current: $4.43
Upside: +758.76%
PTC Therapeutics
May 8, 2025
Maintains: Equal-Weight
Price Target: $56$42
Current: $48.74
Upside: -13.83%
Cytokinetics
May 8, 2025
Maintains: Overweight
Price Target: $55$53
Current: $36.63
Upside: +44.71%
Maintains: Equal-Weight
Price Target: $8$11
Current: $9.06
Upside: +21.41%
Maintains: Equal-Weight
Price Target: $31$25
Current: $21.46
Upside: +16.50%
Maintains: Equal-Weight
Price Target: $45$40
Current: $32.79
Upside: +21.99%
Maintains: Overweight
Price Target: $26$31
Current: $5.93
Upside: +422.77%
Maintains: Overweight
Price Target: $55$26
Current: $12.13
Upside: +114.34%
Maintains: Equal-Weight
Price Target: $435$467
Current: $478.97
Upside: -2.50%
Maintains: Equal-Weight
Price Target: $5$3
Current: $3.08
Upside: -2.60%
Maintains: Underweight
Price Target: $3$4
Current: $4.44
Upside: -9.91%
Maintains: Overweight
Price Target: $295$329
Current: $320.87
Upside: +2.53%
Maintains: Overweight
Price Target: $110$86
Current: $59.67
Upside: +44.13%
Maintains: Overweight
Price Target: $55$50
Current: $9.17
Upside: +445.26%
Maintains: Overweight
Price Target: $83$81
Current: $41.44
Upside: +95.46%
Maintains: Overweight
Price Target: $93$94
Current: $39.46
Upside: +138.25%
Maintains: Equal-Weight
Price Target: $7$9
Current: $13.57
Upside: -33.68%
Upgrades: Equal-Weight
Price Target: $16$25
Current: $14.79
Upside: +69.03%
Maintains: Overweight
Price Target: $32$18
Current: $8.37
Upside: +115.18%
Maintains: Underweight
Price Target: $21$9
Current: $3.60
Upside: +150.00%
Initiates: Buy
Price Target: $275
Current: $5.83
Upside: +4,616.98%